Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
Line 19: | Line 19: | ||
===Single-agent immunotherapy=== | ===Single-agent immunotherapy=== | ||
===Single-agent targeted therapy=== | ===Single-agent targeted therapy=== | ||
+ | ==Multi-agent regimen== | ||
=More specific classes= | =More specific classes= |
Revision as of 12:23, 13 December 2022
The purpose of this page is to define regimen classes that will be used in the HemOnc ontology; it is not for other purposes at this time.